JCR Pharmaceuticals News and Activities
Presence
JCR Pharmaceuticals develops, makes, and sells specialty medicines and related services. Its main products include therapies for rare diseases and regenerative medicine, serving hospitals, physicians, and patients in Japan and overseas.
JCR Pharmaceuticals products and services overview:
- Rare disease drugs
- Biologics manufacturing
- Regenerative medicine
- Growth hormone therapy
- Enzyme replacement therapies
- Contract development services
Revenue: ~$260 million
Employees: 980
Headquarters: Ashiya, Japan
JCR Pharmaceuticals is one of the...
JCR Pharmaceuticals is a company listed under the stock ticker 4552 (JP).
Executives
View the org chart displaying its 21 main executives
Most searched biographies at JCR Pharmaceuticals
- Shin Ashida, Representative Director Chairman, President and Chief...
- Yuko Hayashi, Independent Director
- Miya Miyama, Director
Create your alert
to follow the executive moves at JCR Pharmaceuticals.
Pharmaceuticals
JCR Pharmaceuticals has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by JCR Pharmaceuticals
Social media about JCR Pharmaceuticals
- JCR Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- JCR Pharmaceuticals on LinkedIn, X (Twitter) & YouTube
